Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring

Blood drawn for biomarker analysis at baseline and study exit. Finger sticks at baseline, interim, and study exit.

Continuous monitoring of Patient Reported Informatics (PRIs) at study entry to study completion.

Symptom and quality of life questionnaire at baseline, and every week following to study completion